Max Chan
Financieel Directeur/CFO bij FORESEE PHARMACEUTICALS CO., LTD.
Actieve functies van Max Chan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JHL BIOTECH, INC. | Comptroller/Controller/Auditor | 20-10-2015 | - |
| Financieel Directeur/CFO | 20-10-2015 | 01-05-2018 | |
| FORESEE PHARMACEUTICALS CO., LTD. | Financieel Directeur/CFO | 07-10-2019 | - |
| Public Communications Contact | 07-10-2019 | - | |
| Himax Taiwan, Inc. | Financieel Directeur/CFO | 08-03-2010 | - |
| Himax Media Solutions, Inc. | Directeur/Bestuurslid | 08-03-2010 | - |
| Himax Imaging Ltd. | Directeur/Bestuurslid | 08-03-2010 | - |
Wisepal Technologies, Inc.
 Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Directeur/Bestuurslid | 08-03-2010 | - |
| Harvest Investments Ltd. | Directeur/Bestuurslid | 09-12-2010 | - |
| Himax Semiconductor Ltd. | Directeur/Bestuurslid | 09-12-2010 | - |
Loopbaan van Max Chan
Eerdere bekende functies van Max Chan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OBI PHARMA, INC. | Operationeel Directeur | 01-01-2010 | - |
| Financieel Directeur/CFO | 01-01-2010 | 01-01-2019 | |
| Public Communications Contact | 01-01-2010 | 01-01-2019 | |
| Corporate Officer/Principal | 01-01-2010 | - | |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Max Chan
| National Taiwan University | Masters Business Admin |
| University of Illinois | Graduate Degree |
Statistieken
Internationaal
| Taiwan | 13 |
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director of Finance/CFO | 6 |
| Director/Board Member | 5 |
| Corporate Officer/Principal | 4 |
Sectoraal
| Health Technology | 5 |
| Electronic Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| HIMAX TECHNOLOGIES, INC. | Electronic Technology |
| INTEL CORPORATION | Electronic Technology |
| OBI PHARMA, INC. | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| Bedrijven in privébezit | 10 |
|---|---|
| Himax Taiwan, Inc. | |
| Himax Media Solutions, Inc. | |
| Himax Imaging Ltd. | |
Wisepal Technologies, Inc.
Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Distribution Services |
| Harvest Investments Ltd. | |
| Himax Semiconductor Ltd. | |
| Credit Suisse First Boston Asia International (Cayman) Ltd. | |
CDIB Capital Group
 CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Finance |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
